Otc - Active Ingredient
AVOBENZONE
Ponds Clarant B3
FDA Label NDC 69772-615
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Teresa Cecena Dba Genesis for the product Ponds Clarant B3 (NDC 69772-615). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Water, myristic acid,stearic acid,niacinamide,ethylhexyl methoxycinnamate,glycerin, tapioca starch, triethanolamine, cyclopentasiloxane,PEG/PPG-18/18 dimethocone, cetyl alcohol, butyl methpxydibenzoylmethane, phnpxyethanol,fragance, carbomer, acrylates crosspolymer, methylparabene,propylparabene, disodium EDTA, sodium ascorbyl phosphate.
Warnings
FOR EXTERNAL USE ONLY.
AVOID CONTACT WITH EYES. If product gets into eyes, rinse thoroughly with water.
Discontinue use and consult a physican:
If you experience some irritation rash or other adverse reaction
Dosage & Administration
Apply daily to face and ne ck. For best results, apply during the morning ( as a base for your make-up) and night.
Package Label.Principal Display Panel
Ponds Clarants B (B3label1)
* Please review the disclaimer below.
